GATA2 gene mutation can indicate risk of blood cancers

09/5/2011 | Sydney Morning Herald (Australia), The

Australian researchers have found that mutations in the GATA2 gene could indicate that a person is more vulnerable to developing blood cancers such as myelodysplastic syndrome and acute myeloid leukemia. The gene influences the functions of genes involved in the production of white blood cells. A clinical trial is being undertaken in the U.S. to explore treatment options.

View Full Article in:

Sydney Morning Herald (Australia), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI